CAI (Caris Life Sciences) Accounts Payable: $69.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CAI Caris Life Sciences Inc CAI
11 GF Score
Price $15.53
! 2 Warning Signs
View Full Analysis

What is Caris Life Sciences Accounts Payable?

Caris Life Sciences CAI -0.89% 11 Accounts Payable is $69.8 Mil as of Mar. 2026. GuruFocus rates CAI with a GF Score™ of 11/100. The stock has 2 warning signs investors should review.

Caris Life Sciences's Accounts Payable for the quarter that ended in Mar. 2026 was $69.8 Mil.

Caris Life Sciences's quarterly Accounts Payable increased from Sep. 2025 ($29.0 Mil) to Dec. 2025 ($39.2 Mil) and increased from Dec. 2025 ($39.2 Mil) to Mar. 2026 ($69.8 Mil).

Caris Life Sciences's annual Accounts Payable increased from Dec. 2023 ($26.7 Mil) to Dec. 2024 ($27.8 Mil) and increased from Dec. 2024 ($27.8 Mil) to Dec. 2025 ($39.2 Mil).

Caris Life Sciences Accounts Payable Related Terms

Caris Life Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Caris Life Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caris Life Sciences Accounts Payable Chart

Caris Life Sciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
27.27 26.68 27.79 39.21

Caris Life Sciences Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 24.23 28.73 29.00 39.21 69.80
CAI
11GF Score
Caris Life Sciences Inc CAI
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caris Life Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $69.8 Mil mean?
Caris Life Sciences (CAI) has a Accounts Payable of $69.8 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Caris Life Sciences and its competitors.
Is Caris Life Sciences' Accounts Payable too high?
Caris Life Sciences' current Accounts Payable is $69.8 Mil. Overall, Caris Life Sciences has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Caris Life Sciences' Accounts Payable compare to DNTH and MANE?
Caris Life Sciences' Accounts Payable of $69.8 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Caris Life Sciences and its competitors. Caris Life Sciences's current Accounts Payable is $69.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caris Life Sciences stock overvalued right now?
Caris Life Sciences (CAI) has a current Accounts Payable of $69.8 Mil. The current Accounts Payable is $69.8 Mil. Caris Life Sciences' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Caris Life Sciences (CAI), the current Accounts Payable is $69.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Caris Life Sciences Business Description

Other Exchanges CAI:Mexico49J:Germany
Address 750 W. John Carpenter Freeway, Suite 800, Irving, TX, USA, 75039
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
11GF Score

Get the complete analysis for CAI

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.53
Price